Real-world study of aortic valve replacement
Part of Heart & circulation clinical trials.
This trial is studying how well a new type of heart valve works in real-life patients with aortic valve disease. It will help doctors understand if this valve is safe and effective for people who need a procedure called TAVR (transcatheter aortic valve replacement).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have aortic valve disease and your heart team has said you need a TAVR procedure.
- You understand the study and agree to take part by signing a consent form.
- You are not pregnant or breastfeeding (if you are a woman who could become pregnant).
- You are not taking part in another clinical trial for a drug or device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure called TAVR to replace the aortic valve in people with severe aortic regurgitation (a leaky valve). It may help you if you have this condition and prefer a less invasive option than open-heart surgery.
This trial follows people who have severe aortic valve regurgitation and get a TAVR. It looks at how well the valve works over time and how patients do in the long run.
This trial studies people with severe aortic valve disease who will receive a catheter-based valve replacement (TAVR). It aims to check how well this approach works for fixing a narrowed or leaky aortic valve, and to monitor outcomes afterward.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This trial studies a less invasive heart valve procedure that places a new valve through a catheter, to treat severe leakage of the aortic valve. It may help people who have symptoms or heart enlargement and who are at higher risk for open-heart surgery.
This study is a real-world registry that collects information from people who receive TAVI, a procedure to treat a damaged heart valve. It may help doctors understand outcomes and improve care, even though it isn’t testing a new drug.
Hear when a new Aortic Valve Disease Mixed trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.